Accounts Receivable |
3 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Accounts Receivable [Abstract] | |||||||||||||||||||||||||||||||||||||
| ACCOUNTS RECEIVABLE |
NOTE 3 – ACCOUNTS RECEIVABLE
On March 31, 2024 and December 31, 2023, accounts receivable consisted of the following:
For the three months ended March 31, 2024 and 2023, bad debt expense amounted to $29,984 and $0, respectively. |
||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- Definition The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|